Literature DB >> 2389421

The immunosuppressive agent 15-deoxyspergualin induces tolerance and modulates MHC-antigen expression and interleukin-1 production in the early phase of rat allograft responses.

A M Waaga1, K Ulrichs, M Krzymanski, J Treumer, M L Hansmann, T Rommel, W Müller-Ruchholtz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2389421

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.

Authors:  K Morikawa; K Nemoto; T Miyawaki; S Morikawa
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

2.  Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.

Authors:  S Jung; K V Toyka; H P Hartung
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

3.  The immunosuppressant 15-deoxyspergualin [correction of 1,5-deoxyspergualin] reveals commonality between preT and preB cell differentiation.

Authors:  B Wang; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.